In 2024, per member per month (PMPM) spending for asthma and COPD (chronic obstructive pulmonary disease) prescription drug is forecasted to be around 2.35 U.S. dollars per member per month in the United States. This statistic illustrates the forecast of asthma prescription drug PMPM spending in the United States from 2019 to 2024.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Magellan Rx. (May 4, 2021). Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/
Magellan Rx. "Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars)." Chart. May 4, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/
Magellan Rx. (2021). Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/
Magellan Rx. "Asthma and Copd Drug Pmpm Spending in The United States from 2019 to 2024 (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 4 May 2021, /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/
Magellan Rx, Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/ (last visited July 24, 2026)
Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars) [Graph], Magellan Rx, May 4, 2021. [Online]. Available: /statistics/1183948/forecast-asthma-copd-drug-pmpm-spending/
